Online citations, reference lists, and bibliographies.

Major Vascular Resection In Pancreatic Carcinoma

Karl-Frederick Karstens, Y. Vashist, J. Izbicki
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Pancreatic cancer (PDAC) is one of the leading causes of cancer-related death worldwide. The incidence of PDAC is rising and mortality despite the effort to develop and implement new therapeutic strategies is increasing [1] (The Cancer Statistics Review (2009–2013) online). The major problem to improve individual survival rates is the delayed diagnosis of PDAC. Consequently, the majority of patients have to be excluded from surgical resection due to an already distant spread or locally advancement of the disease. Hence, only 10–20% of PDAC patients are primarily eligible for potential curative surgical approach aiming at a complete oncologic resection of the carcinoma with negative margins (R0). Despite controversies in definition of true R0 resection in PDAC and lessons learned in histological workup of the specimen, tumor-free resection margins still remain the goal of radical operation in PDAC with a reported prolonged survival of 5-year survival rates of up to 25% in selected series [2–7].
This paper references
10.1111/j.1477-2574.2009.00055.x
Redefining resection margin status in pancreatic cancer.
C. Verbeke (2009)
10.1245/ASO.2006.08.011
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
G. Varadhachary (2006)
10.1111/ans.13249
Artery first approach to pancreatoduodenectomy: current status
S. Pandanaboyana (2016)
10.1007/s11605-011-1753-x
A Root-Cause Analysis of Mortality Following Major Pancreatectomy
C. M. Vollmer (2011)
10.1016/S0002-9610(01)00686-9
Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?
P. Bachellier (2001)
10.1007/s11605-008-0791-5
Vascular Resection in Pancreatic Cancer Surgery: Survival Determinants
Sascha A. Müller (2008)
10.1097/SLA.0b013e31815aab22
En Bloc Vascular Resection for Locally Advanced Pancreatic Malignancies Infiltrating Major Blood Vessels: Perioperative Outcome and Long-term Survival in 136 Patients
E. Yekebas (2008)
10.1016/j.hpb.2015.11.009
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma.
J. Butler (2016)
10.1016/S1091-255X(00)80105-5
Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators
T. Sohn (2000)
10.1245/s10434-013-3431-6
Posterior ‘Superior Mesenteric Artery First’ Approach for Resection of Locally Advanced Pancreatic Cancer
J Bart Rose (2013)
10.1097/01.sla.0000259391.84304.2b
Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
C. Raut (2007)
10.1016/j.amjsurg.2013.01.040
The clinical impact of early complete pancreatic head devascularisation during pancreatoduodenectomy.
J. Gundara (2013)
10.1016/j.jamcollsurg.2009.10.019
The "artery first" approach for resection of pancreatic head cancer.
J. Weitz (2010)
10.1038/bjc.2016.45
Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
S. Stein (2016)
10.1002/bjs.5368
Systematic review of outcome of synchronous portal–superior mesenteric vein resection during pancreatectomy for cancer
H. Siriwardana (2006)
10.1016/j.hpb.2015.10.012
Early biliary complications following pancreaticoduodenectomy: prevalence and risk factors.
Brice Malgras (2016)
10.1097/MPA.0b013e318221c595
Clinical Significance of Portal-Superior Mesenteric Vein Resection in Pancreatoduodenectomy for Pancreatic Head Cancer
Sung-Sik Han (2012)
10.1245/s10434-013-2886-9
Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
M. Katz (2013)
10.1093/annonc/mdt301
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980.
C. Bosetti (2013)
10.1016/j.ijscr.2016.04.014
Replaced gastroduodenal artery: Added benefit of the “artery first” approach during pancreaticoduodenectomy—A case report
George Younan (2016)
10.1001/archsurg.2008.547
Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
R. Martin (2009)
10.1002/cncr.27636
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
M. Katz (2012)
10.1007/s11605-007-0296-7
Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Feasibility, Efficacy, and Survival
John D. Allendorf (2007)
10.1097/MD.0000000000002529
Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters
Ulrich F Wellner (2016)
10.1007/s00268-012-1461-z
Pancreatectomy Combined with Superior Mesenteric Vein–Portal Vein Resection for Pancreatic Cancer: A Meta-analysis
Y. Zhou (2012)
10.1097/MD.0000000000003061
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Cancer
Haibing Gong (2016)
10.1016/j.pan.2012.03.057
Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.
Y. Zhang (2012)
A Novel "Artery First" Approach Allowing Safe Resection in Laparoscopic Pancreaticoduodenectomy: The Uncinate Process First Approach.
Y. Nagakawa (2015)
10.3322/canjclin.44.2.71
Clinical highlights from the national cancer data base: 1994
G. Steele (1994)
10.1016/j.surg.2012.05.012
Vascular invasion in pancreatic cancer: tumor biology or tumor topography?
A. Rehders (2012)
10.1007/S00534-004-0939-Y
The significance of intraoperative Doppler ultrasonography in evaluating hepatic arterial flow when assessing the indications for the Appleby procedure for pancreatic body cancer.
I. Hirai (2005)
10.1097/MPA.0000000000000634
Treatment Strategy for Borderline Resectable Pancreatic Cancer With Radiographic Artery Involvement
S. Hirono (2016)
10.1016/j.surg.2008.12.009
Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.
Y. Kaneoka (2009)
10.1245/s10434-011-1900-3
Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades
J. Winter (2011)
10.1016/j.gassur.2005.05.001
Pancreaticoduodenectomy: Superior mesenteric artery first approach
P. Pessaux (2007)
10.1002/bjs.9799
Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma
Y. Murakami (2015)
10.1016/j.jamcollsurg.2008.04.033
Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer.
K. Bilimoria (2008)
10.3748/WJG.V16.I7.818
Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.
N. Buchs (2010)
10.1097/SLA.0000000000000867
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
C. Ferrone (2015)
10.1038/bjc.2016.55
Long-term impact of preeclampsia on maternal endometrial cancer risk
Sara Hallum (2016)
10.1259/bjr/21236482
Anatomical variations of hepatic arterial system, coeliac trunk and renal arteries: an analysis with multidetector CT angiography.
M S Ugurel (2010)
10.3978/j.issn.2078-6891.2015.093
Management of the right hepatic artery in pancreaticoduodenectomy: a systematic review.
Mehdi El Amrani (2016)
10.1055/S-0033-1356220
S3-Leitlinie zum exokrinen Pankreaskarzinom
T. Seufferlein (2013)
10.1002/1097-0142(195307)6:4<704::AID-CNCR2820060410>3.0.CO;2-P
The coeliac axis in the expansion of the operation for gastric carcinoma
L. Appleby (1953)
10.1097/MPA.0000000000000314
FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer: A Meta-Analytical Review of Published Studies
F. Petrelli (2015)
10.1097/SLA.0b013e31823ac299
Arterial Resection During Pancreatectomy for Pancreatic Cancer: A Systematic Review and Meta-Analysis
N. Mollberg (2011)
10.1002/bjs.5612
Authors' reply: Systematic review of outcome of synchronous portal‐superior mesenteric vein resection during pancreatectomy for cancer (Br J Surg 2006; 93: 662 –673)
A. Sheen (2006)
10.1111/j.1477-2574.2012.00571.x
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
R. Lewis (2013)
10.3322/canjclin.46.3.185
Clinical highlights from the National Cancer Data Base: 1996
J. Jessup (1996)
10.1097/PAS.0b013e318065bfe6
Detail Histologic Analysis of Nerve Plexus Invasion in Invasive Ductal Carcinoma of the Pancreas and Its Prognostic Impact
Shuichi Mitsunaga (2007)
10.1007/s11605-012-1925-3
Modified Appleby Procedure for Resection of Tumors of the Pancreatic Body and Tail with Celiac Axis Involvement
Rory L Smoot (2012)
10.1007/s11605-015-3001-2
Modified Appleby Procedure with Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma: A Literature Review and Report of Three Unusual Cases
Jessica A. Latona (2015)
10.6092/1590-8577/1724
Neoadjuvant chemo-radiotherapy for patients with borderline resectable pancreatic cancer: a meta-analytical evaluation of prospective studies.
V. Festa (2013)
10.1097/01.mcg.0000225672.68852.05
The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic Cancer
S. Bang (2006)
10.3748/wjg.v19.i46.8740
Vascular resection in pancreatic adenocarcinoma with portal or superior mesenteric vein invasion.
Gang Pan (2013)
10.1016/0002-9610(66)90201-7
Newer anatomy of the liver and its variant blood supply and collateral circulation.
N. Michels (1966)
10.1245/s10434-008-0281-8
Does Portal-Superior Mesenteric Vein Invasion Still Indicate Irresectability for Pancreatic Carcinoma?
G. Ramacciato (2008)
10.1007/s00268-014-2808-4
Resection Margin Clearance in Pancreatic Cancer After Implementation of the Leeds Pathology Protocol (LEEPP): Clinically Relevant or Just Academic?
F. Gebauer (2014)
10.1016/j.gassur.2004.09.046
Pancreaticoduodenectomy with vascular resection: margin status and survival duration
J. Tseng (2007)
10.1016/j.surg.2014.02.001
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).
M. Bockhorn (2014)
10.1007/s11605-009-1129-7
Extended Pancreaticoduodenectomy with Vascular Resection for Pancreatic Cancer: A Systematic Review
T. Chua (2009)
10.1097/SLA.0000000000001065
Pancreatoduodenectomy With Systematic Mesopancreas Dissection Using a Supracolic Anterior Artery-first Approach
Y. Inoue (2015)
10.1016/j.surg.2014.02.009
Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS).
W. Hartwig (2014)
10.1007/s11605-013-2178-5
Vein Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of “Borderline Resectable Disease”?
K. Kelly (2013)
10.1007/s11605-015-2958-1
Cattell-Braasch Maneuver Combined with Artery-First Approach for Superior Mesenteric-Portal Vein Resection During Pancreatectomy
M. Del Chiaro (2015)
10.1097/MPA.0000000000000524
Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma: A Meta-Analysis
J. Treadwell (2016)



Semantic Scholar Logo Some data provided by SemanticScholar